Immune disease biopharmaceutical company Attovia (ATTO.US) applies for listing in the United States, planning to raise $100 million.

Zhtng cijng APP hu x, lnchung jidun shngw zhyo gngs Attovia Therapeutics y tgng shuc gngk (IPO) shnqng, jhu mj zu du 1 y miyun zjn. Gi gngs jhu zi Nsd ksh, gpio dim wi "ATTO".